Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296127 · ClinicalTrials.gov registry record · Phase 1
Study of Celecoxib Bioavailability in Healthy Subjects
A Phase 1 study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00296127 is a Phase 1 study that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 24 participants.
The verdict
NCT00296127, a Phase 1 study, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule
Interventions
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296127
The ClinicalTrials.gov registry entry for NCT00296127 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Celecoxib is the first listed.
NCT00296127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00296127 about?
NCT00296127 is a clinical study titled "Study of Celecoxib Bioavailability in Healthy Subjects". To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule
What is the current status of trial NCT00296127?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2006-02. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00296127?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00296127?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.